Catalyst Wire Dossier Catalyst Wire Dossier

SYNSORB Pk

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYNSORB Pk, covering 2017-06-01 to 2017-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome [Phase 3]

See pricing